Paul M. Ridker
Divisions of Preventive Medicine
Cardiovascular Diseases
Department of Medicine
Brigham and Women's Hospital
USA
Name/email consistency: high
- C-reactive protein, inflammation, and coronary risk. Ridker, P.M., Morrow, D.A. Cardiol. Clin (2003)
- G20210A mutation in prothrombin gene and risk of myocardial infarction, stroke, and venous thrombosis in a large cohort of US men. Ridker, P.M., Hennekens, C.H., Miletich, J.P. Circulation (1999)
- Prospective study of Chlamydia pneumoniae IgG seropositivity and risks of future myocardial infarction. Ridker, P.M., Kundsin, R.B., Stampfer, M.J., Poulin, S., Hennekens, C.H. Circulation (1999)
- Inflammation, atherosclerosis, and cardiovascular risk: an epidemiologic view. Ridker, P.M. Blood Coagul. Fibrinolysis (1999)
- Homocysteine and risk of cardiovascular disease among postmenopausal women. Ridker, P.M., Manson, J.E., Buring, J.E., Shih, J., Matias, M., Hennekens, C.H. JAMA (1999)
- Evaluating novel cardiovascular risk factors: can we better predict heart attacks?. Ridker, P.M. Ann. Intern. Med. (1999)
- Hormone replacement therapy and increased plasma concentration of C-reactive protein. Ridker, P.M., Hennekens, C.H., Rifai, N., Buring, J.E., Manson, J.E. Circulation (1999)
- Plasma concentration of soluble intercellular adhesion molecule 1 and risks of future myocardial infarction in apparently healthy men. Ridker, P.M., Hennekens, C.H., Roitman-Johnson, B., Stampfer, M.J., Allen, J. Lancet (1998)
- Plasma concentration of C-reactive protein and risk of developing peripheral vascular disease. Ridker, P.M., Cushman, M., Stampfer, M.J., Tracy, R.P., Hennekens, C.H. Circulation (1998)
- C-reactive protein adds to the predictive value of total and HDL cholesterol in determining risk of first myocardial infarction. Ridker, P.M., Glynn, R.J., Hennekens, C.H. Circulation (1998)
- Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women. Ridker, P.M., Buring, J.E., Shih, J., Matias, M., Hennekens, C.H. Circulation (1998)
- Inflammation, pravastatin, and the risk of coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events (CARE) Investigators. Ridker, P.M., Rifai, N., Pfeffer, M.A., Sacks, F.M., Moye, L.A., Goldman, S., Flaker, G.C., Braunwald, E. Circulation (1998)
- Prospective study of herpes simplex virus, cytomegalovirus, and the risk of future myocardial infarction and stroke. Ridker, P.M., Hennekens, C.H., Stampfer, M.J., Wang, F. Circulation (1998)
- Interrelation of hyperhomocyst(e)inemia, factor V Leiden, and risk of future venous thromboembolism. Ridker, P.M., Hennekens, C.H., Selhub, J., Miletich, J.P., Malinow, M.R., Stampfer, M.J. Circulation (1997)
- Ethnic distribution of factor V Leiden in 4047 men and women. Implications for venous thromboembolism screening. Ridker, P.M., Miletich, J.P., Hennekens, C.H., Buring, J.E. JAMA (1997)
- Fibrinolytic and inflammatory markers for arterial occlusion: the evolving epidemiology of thrombosis and hemostasis. Ridker, P.M. Thromb. Haemost. (1997)
- Alu-repeat polymorphism in the gene coding for tissue-type plasminogen activator (t-PA) and risks of myocardial infarction among middle-aged men. Ridker, P.M., Baker, M.T., Hennekens, C.H., Stampfer, M.J., Vaughan, D.E. Arterioscler. Thromb. Vasc. Biol. (1997)
- Intrinsic fibrinolytic capacity and systemic inflammation: novel risk factors for arterial thrombotic disease. Ridker, P.M. Haemostasis (1997)